Elizabeth Murphy Lilly - 21 Jun 2023 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role: Director
Signature: /s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Issuer symbol: APOG
Transactions as of: 21 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2023, 18:51:36 UTC
Previous filing: 23 Jun 2022
Next filing: 03 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APOG	Common Stock	Award	$0	+602	+5.1%	$0.000000	12,488	21 Jun 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APOG	Deferred Restricted Stock Units	Award	$0	+1,807		$0.000000	1,807	21 Jun 2023	Common Stock	1,807	$0.000000	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares vest over a three year vesting period with one-third of the shares vesting on each anniversary of the award.
F2	Includes restricted stock awards under the 2019 Non-Employee Director Stock Plan.
F3	Settled 1-for-1.
F4	The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.